文献速递肿瘤 PET/CT神经核医学

比较⁶⁸Ga-DOTATATA PET/CT、FDG PET/CT与MIBG SPECT/CT在疑似原发性嗜铬细胞瘤和副神经节瘤评估中的价值

Comparison of the 68Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT in the Evaluation of Suspected Primary Pheochromocytomas and Paragangliomas.
PubMed 文献 · Clin Nucl Med · 2017-01-01

纳入9例疑似或已知原发性嗜铬细胞瘤/副神经节瘤患者,均行⁶⁸Ga-DOTATATA PET/CT、FDG PET/CT和MIBG SPECT/CT检查并与术后病理及随访对比。⁶⁸Ga-DOTATATA PET/CT和MIBG SPECT/CT均准确识别9个原发肿瘤,FDG PET/CT显示8/9原发肿瘤活性增高。⁶⁸Ga-DOTATATA PET/CT可能是评估疑似原发性嗜铬细胞瘤或副神经节瘤的核医学影像选择,尤其在多发性内分泌腺瘤病综合征情况下。

要点

  • ⁶⁸Ga-DOTATATA PET/CT和MIBG SPECT/CT均准确识别9个原发肿瘤。
  • FDG PET/CT显示9个原发肿瘤中8个活性增高。
  • ⁶⁸Ga-DOTATATA和FDG PET/CT能检出MIBG未显示的相关肾上腺外病灶。

核心结论

  • ⁶⁸Ga-DOTATATA PET/CT可能是评估疑似原发性嗜铬细胞瘤或副神经节瘤的核医学影像选择,尤其在多发性内分泌腺瘤病综合征情况下。

研究设计与样本

  • 纳入8例疑似原发性嗜铬细胞瘤或原发性副神经节瘤患者和1例已知嗜铬细胞瘤患者。
  • 8例未明确诊断者中7例由解剖影像提示,其中1例初始解剖影像判读为阴性。
  • 9例患者均行⁶⁸Ga-DOTATATA PET/CT、FDG PET/CT和MIBG SPECT/CT检查,影像所见与术后病理及随访对比。

主要发现

  • ⁶⁸Ga-DOTATATA PET/CT和MIBG SPECT/CT均准确识别9个原发肿瘤。
  • FDG PET/CT显示9个原发肿瘤中8个活性增高。
  • ⁶⁸Ga-DOTATATA和FDG PET/CT均能检出多发性内分泌腺瘤病综合征患者中MIBG检查未显示的相关肾上腺外病灶。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Anatomical imaging modalities including CT and MRI are the mainstay of evaluation of primary pheochromocytoma or paraganglioma. However, nuclear medicine imaging is frequently necessary to determine the nature of the lesions. The purpose of this investigation is to assess which commonly used nuclear medicine modality might have a better diagnostic value in this clinical setting. METHODS: Eight patients who had been suspected of having either primary pheochromocytoma or primary paraganglioma and 1 patient with known pheochromocytoma were included in the analysis. Among the 8 patients without known diagnosis, 7 had been suggested by anatomical imaging modalities, whereas one of them presented with initial negative anatomical imaging interpretation. All of 9 patients underwent Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT for further evaluation. The imaging findings were compared with postsurgical pathology and follow-up. RESULTS: Both Ga-DOTATATA PET/CT and MIBG SPECT/CT accurately identified 9 primary tumors, whereas FDG PET/CT showed increased activity in 8 of 9 primary tumors. Both Ga-DOTATATA and FDG PET/CT are able to detect associated extra-adrenal lesions not shown on MIBG study in patients with multiple endocrine neoplasia syndrome. CONCLUSIONS: Ga-DOTATATA PET/CT could be the nuclear medicine imaging choice to evaluate suspected primary pheochromocytoma or paraganglioma, especially in the situation of multiple endocrine neoplasia syndrome.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Jing H, Li F, Wang L, et al. Comparison of the 68Ga-DOTATATA PET/CT, FDG PET/CT, and MIBG SPECT/CT in the Evaluation of Suspected Primary Pheochromocytomas and Paragangliomas. Clin Nucl Med. 2017. PMID: 28481789. doi:10.1097/RLU.0000000000001674

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。